A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [14 C]Prucalopride...
A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [14 C]Prucalopride After a Single Oral Dose in Healthy Volunteers
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Abstract Purpose Chronic constipation is a prevalent gastrointestinal disorder globally. It is often treated with medications such as laxatives. Newer therapies to improve gastric motility include the selective 5-hydroxytryptamine receptor-4 agonist prucalopride, which is licensed for the treatment of chronic constipation in adults. The aim of this...
Alternative Titles
Full title
A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [14 C]Prucalopride After a Single Oral Dose in Healthy Volunteers
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1827909800
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1827909800
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2016.08.003
